D. E. Shaw & Co., Inc. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$43,000
-91.4%
36,133
-95.5%
0.00%
-100.0%
Q2 2022$502,000
-60.7%
795,187
-29.0%
0.00%0.0%
Q1 2022$1,277,000
-64.2%
1,120,363
-29.3%
0.00%
-66.7%
Q4 2021$3,565,000
-53.2%
1,584,460
-28.9%
0.00%
-57.1%
Q3 2021$7,619,000
+2258.8%
2,227,534
+1962.1%
0.01%
Q2 2021$323,000
+1600.0%
108,025
+958.0%
0.00%
Q1 2019$19,000
-64.8%
10,210
-48.3%
0.00%
Q3 2018$54,000
-90.4%
19,745
-95.3%
0.00%
-100.0%
Q3 2017$561,000
-16.0%
421,544
-0.9%
0.00%0.0%
Q2 2017$668,000
+5.4%
425,562
+116.6%
0.00%0.0%
Q1 2017$634,000
+53.1%
196,464
-35.9%
0.00%0.0%
Q4 2016$414,000
+8.7%
306,529
+25.7%
0.00%0.0%
Q3 2016$381,000
+24.9%
243,767
+6.6%
0.00%0.0%
Q2 2016$305,000
-84.5%
228,615
-38.6%
0.00%
-75.0%
Q1 2016$1,963,000
-28.5%
372,456
+6.5%
0.00%0.0%
Q4 2015$2,745,000
+29.8%
349,705
+39.7%
0.00%
+33.3%
Q3 2015$2,115,000
-51.7%
250,306
-37.4%
0.00%
-57.1%
Q2 2015$4,378,000
-33.9%
399,818
-15.6%
0.01%
-30.0%
Q1 2015$6,621,000
+3.6%
473,576
+25.1%
0.01%
+25.0%
Q4 2014$6,392,000
-0.5%
378,473
-20.9%
0.01%0.0%
Q3 2014$6,423,000
+37.4%
478,607
+30.4%
0.01%
+33.3%
Q2 2014$4,676,000
+136.5%
367,063
+120.7%
0.01%
+100.0%
Q1 2014$1,977,000
-17.0%
166,339
-3.6%
0.00%0.0%
Q4 2013$2,382,000
-60.4%
172,464
-50.0%
0.00%
-70.0%
Q3 2013$6,020,000
-41.5%
344,969
-45.5%
0.01%
-47.4%
Q2 2013$10,282,000632,7530.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders